Tumor chromosomal translocations reproduced for the first time in human cells

June 3, 2014, Centro Nacional de Investigaciones Oncologicas (CNIO)
Tumor chromosomal translocations reproduced for the first time in human cells
Shown are translocations of chromosomes 11 (green) and 13 (red), implicated in Ewing' sarcoma, obtained using the RGEN genetic tool. Credit: CNIO

Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells, chromosomal translocations associated with two types of cancer: acute myeloid leukaemia and Ewing's sarcoma. The discovery, published today in the journal Nature Communications, opens the door to the development of new therapeutic targets to fight these types of cancer.

The study was carried out by Sandra Rodriguez-Perales − from CNIO's Molecular Cytogenetics Group, led by Juan Cruz Cigudosa − and Juan Carlos Ramírez and Raúl Torres, from CNIC's Viral Vector Technical Unit. The researchers have shown that it is possible to produce chromosome modifications in that are genetically identical to those observed in leukaemia and other types of human cancer.

This new technology offers two main advantages based on the use of molecular tools to manipulate the genome: firstly, working models that had not existed up until now for the study of tumour biology and, secondly, their application will eventually allow for the study of new therapeutic targets and therapies.

The alterations leading to tumour development are due to multiple changes in cell physiology and specifically in the cell genome. In leukaemia and other tumours called sarcomas, exchanges of large DNA fragments occur between different chromosomes, a phenomenon known as chromosomal translocations. As the study's authors point out, these translocations are necessary both for the generation and the progression of a number of neoplastic processes.

"The study of this type of tumours has been problematic up to now due to the lack of cell models and the appropriate animal models", says CNIC researcher Juan Carlos Ramírez, who adds that the difficulty of generating these chromosomal translocations had limited the availability of cells with this mark of the disease.

Breaking chromosomes to study cancer

Using RNA-Guided Endonuclease (RGEN) technology or CRISPR/Cas9 genome engineering technology, CNIO and CNIC researchers have shown that it is possible to obtain such chromosomal translocations. In this way, they have managed to reproduce chromosomal translocations in human stem cells from blood and mesenchymal tissue that are identical to those observed in patients with acute myeloid leukemia (a blood and bone marrow cancer) or Ewing's sarcoma (a type of bone tumour that affects children and teenagers).

"With this breakthrough it is possible to generate cell models with the same alterations as observed in tumour cells from patients, which will allow us to study their role in tumour development", says CNIO researcher Sandra Rodríguez-Perales. "In this way, it will be possible to experimentally recapitulate the necessary subsequent steps for normal cells to transform into cancer cells".

The researchers have used the powerful RGEN tool, which was developed at the beginning of 2013, for gene manipulation in eukaryotic cells, including human ones. It is based on the design of a small RNA (RNAsg) that is complementary and specific to a 20 nucleotide DNA region. The binding of the RNAsg to the DNA acts as a signal for the Cas9 enzyme to produce a cut on the edge of the marked DNA. The system is very specific and efficient and allows for cuts to be made in the DNA's double helix wherever the researchers need to do so.

Rodríguez-Perales, Torres and Ramírez have shown that by transferring the RGEN components into primary human cells, regions of the exchanged chromosomes in some tumours can be marked, thus generating cuts in those chromosomes.

"When the DNA repair machinery tries to repair those cuts, it drives the generation of a translocation between two different chromosomes, in many cases reciprocally between the two chromosomes implicated", says CNIC researcher Raúl Torres.

The study's authors conclude by stating that the use of this technology will also allow for the clarification of how and why chromosomal translocation occurs, which without doubt will allow new anti-cancer therapeutic strategies to be tackled.

Explore further: A new mechanism that contributes to the evolution of cancer

More information: Engineering human tumor associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Raúl Torres, Maria C. Martin, Aida Garcia, Juan C. Cigudosa, Juan C. Ramirez, Sandra Rodriguez-Perales. Nature Communications (2014). DOI: 10.1038/ncomms4964

Related Stories

A new mechanism that contributes to the evolution of cancer

January 31, 2013
Cancer arises from the accumulation of mutations and structural changes in chromosomes, which in some cases give rise to combinations that favour the growth or expansion of the disease. In this context, chromosomes tend to ...

Scientists resolve how chromosomal mix-ups lead to tumors

March 29, 2012
(Medical Xpress) -- A new study by scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, resolves longstanding questions about ...

Researchers discover new genetic errors that could cause one of the most deadly leukaemias

October 23, 2013
Acute dendritic leukaemia is a rare type of leukaemia, but one with the worst prognosis—the average patient survival rate is just 12-14 months—that is difficult to treat. Juan Cruz Cigudosa's team, from the Spanish National ...

Chromosomal translocations point the way toward personalized cancer care

August 13, 2012
A broken chromosome is like an unmoored beansprout circling in search of attachment. If a cell tries to replicate itself with broken chromosomes, the cell will be killed and so it would very much like to find its lost end. ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.